Th17 cells: a prognostic marker for MS rebound after natalizumab cessation?
Background:Multiple sclerosis (MS) patients are at risk of renewed disease activity after discontinuing natalizumab (NAT) treatment.Objective:Assessing the implication of T helper 17 (Th17) cells in MS reactivation after NAT cessation.Methods:We monitored frequencies of Th17 cells and interleukin (I...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Multiple sclerosis journal
Year: 2016, Jahrgang: 23, Heft: 1, Pages: 114-118 |
| ISSN: | 1477-0970 |
| DOI: | 10.1177/1352458516640609 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1177/1352458516640609 Verlag, Volltext: https://doi.org/10.1177/1352458516640609 
|
| Verfasserangaben: | Jürgen Haas, Katharina Schneider, Alexander Schwarz, Mirjam Korporal-Kuhnke, Simon Faller, Felipe von Glehn, Sven Jarius, Brigitte Wildemann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580547826 | ||
| 003 | DE-627 | ||
| 005 | 20230427065704.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180830r20172016xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1352458516640609 |2 doi | |
| 035 | |a (DE-627)1580547826 | ||
| 035 | |a (DE-576)510547826 | ||
| 035 | |a (DE-599)BSZ510547826 | ||
| 035 | |a (OCoLC)1341017630 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Haas, Jürgen |e VerfasserIn |0 (DE-588)1073216810 |0 (DE-627)828662290 |0 (DE-576)434731749 |4 aut | |
| 245 | 1 | 0 | |a Th17 cells |b a prognostic marker for MS rebound after natalizumab cessation? |c Jürgen Haas, Katharina Schneider, Alexander Schwarz, Mirjam Korporal-Kuhnke, Simon Faller, Felipe von Glehn, Sven Jarius, Brigitte Wildemann |
| 264 | 1 | |c 2017 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published March 21,2016 | ||
| 500 | |a Gesehen am 30.08.2018 | ||
| 520 | |a Background:Multiple sclerosis (MS) patients are at risk of renewed disease activity after discontinuing natalizumab (NAT) treatment.Objective:Assessing the implication of T helper 17 (Th17) cells in MS reactivation after NAT cessation.Methods:We monitored frequencies of Th17 cells and interleukin (IL)-17 cytokine levels in blood samples of 57 MS patients, without, during, and after NAT exposure.Results:Frequencies of both Th17 cells and, in part, also IL-17 levels, in peripheral blood increased under prolonged NAT therapy, returned to baseline after NAT withdrawal and became almost undetectable in blood samples of individuals who experienced relapses during the wash-out phase.Conclusion:Assessing the Th17-cell/IL-17 axis might help to predict rebound MS activity after NAT withdrawal. | ||
| 534 | |c 2016 | ||
| 700 | 1 | |a Schneider, Katharina |d 1988- |e VerfasserIn |0 (DE-588)1051418631 |0 (DE-627)786171162 |0 (DE-576)406441138 |4 aut | |
| 700 | 1 | |a Schwarz, Alexander |d 1976- |e VerfasserIn |0 (DE-588)133590127 |0 (DE-627)549549900 |0 (DE-576)271176261 |4 aut | |
| 700 | 1 | |a Korporal-Kuhnke, Mirjam |d 1975- |e VerfasserIn |0 (DE-588)129891851 |0 (DE-627)483343579 |0 (DE-576)297889583 |4 aut | |
| 700 | 1 | |a Faller, Simon |e VerfasserIn |0 (DE-588)1165827026 |0 (DE-627)1029890706 |0 (DE-576)510557848 |4 aut | |
| 700 | 1 | |a Jarius, Sven |e VerfasserIn |0 (DE-588)1054615918 |0 (DE-627)791654818 |0 (DE-576)410367478 |4 aut | |
| 700 | 1 | |a Wildemann, Brigitte |e VerfasserIn |0 (DE-588)110203844 |0 (DE-627)510150004 |0 (DE-576)171831330 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis journal |d London : Sage, 1995 |g 23(2017), 1, Seite 114-118 |h Online-Ressource |w (DE-627)320468658 |w (DE-600)2008225-3 |w (DE-576)273878239 |x 1477-0970 |7 nnas |a Th17 cells a prognostic marker for MS rebound after natalizumab cessation? |
| 773 | 1 | 8 | |g volume:23 |g year:2017 |g number:1 |g pages:114-118 |g extent:5 |a Th17 cells a prognostic marker for MS rebound after natalizumab cessation? |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/1352458516640609 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1177/1352458516640609 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180830 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 110203844 |a Wildemann, Brigitte |m 110203844:Wildemann, Brigitte |d 910000 |d 911100 |e 910000PW110203844 |e 911100PW110203844 |k 0/910000/ |k 1/910000/911100/ |p 8 |y j | ||
| 998 | |g 1054615918 |a Jarius, Sven |m 1054615918:Jarius, Sven |d 910000 |d 911100 |e 910000PJ1054615918 |e 911100PJ1054615918 |k 0/910000/ |k 1/910000/911100/ |p 7 | ||
| 998 | |g 1165827026 |a Faller, Simon |m 1165827026:Faller, Simon |d 910000 |d 911100 |e 910000PF1165827026 |e 911100PF1165827026 |k 0/910000/ |k 1/910000/911100/ |p 5 | ||
| 998 | |g 129891851 |a Korporal-Kuhnke, Mirjam |m 129891851:Korporal-Kuhnke, Mirjam |d 910000 |d 911100 |e 910000PK129891851 |e 911100PK129891851 |k 0/910000/ |k 1/910000/911100/ |p 4 | ||
| 998 | |g 133590127 |a Schwarz, Alexander |m 133590127:Schwarz, Alexander |d 910000 |d 911100 |e 910000PS133590127 |e 911100PS133590127 |k 0/910000/ |k 1/910000/911100/ |p 3 | ||
| 998 | |g 1051418631 |a Schneider, Katharina |m 1051418631:Schneider, Katharina |d 910000 |d 911100 |e 910000PS1051418631 |e 911100PS1051418631 |k 0/910000/ |k 1/910000/911100/ |p 2 | ||
| 998 | |g 1073216810 |a Haas, Jürgen |m 1073216810:Haas, Jürgen |d 910000 |d 911100 |e 910000PH1073216810 |e 911100PH1073216810 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1580547826 |e 3024206752 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"320468658","titleAlt":[{"title":"Multiple sclerosis"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1995 -"],"part":{"volume":"23","pages":"114-118","extent":"5","year":"2017","issue":"1","text":"23(2017), 1, Seite 114-118"},"disp":"Th17 cells a prognostic marker for MS rebound after natalizumab cessation?Multiple sclerosis journal","origin":[{"dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisherPlace":"London ; Basingstoke, Hampshire ; Basingstoke, Hampshire ; London","publisher":"Sage ; Stockton ; Nature ; Arnold"}],"id":{"zdb":["2008225-3"],"eki":["320468658"],"issn":["1477-0970"]},"note":["Gesehen am 19.01.11"],"language":["eng"],"title":[{"title_sort":"Multiple sclerosis journal","title":"Multiple sclerosis journal"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"given":"Jürgen","role":"aut","display":"Haas, Jürgen","family":"Haas"},{"display":"Schneider, Katharina","family":"Schneider","role":"aut","given":"Katharina"},{"role":"aut","display":"Schwarz, Alexander","family":"Schwarz","given":"Alexander"},{"display":"Korporal-Kuhnke, Mirjam","family":"Korporal-Kuhnke","role":"aut","given":"Mirjam"},{"family":"Faller","display":"Faller, Simon","role":"aut","given":"Simon"},{"display":"Jarius, Sven","family":"Jarius","role":"aut","given":"Sven"},{"given":"Brigitte","role":"aut","display":"Wildemann, Brigitte","family":"Wildemann"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"recId":"1580547826","id":{"doi":["10.1177/1352458516640609"],"eki":["1580547826"]},"note":["First published March 21,2016","Gesehen am 30.08.2018"],"name":{"displayForm":["Jürgen Haas, Katharina Schneider, Alexander Schwarz, Mirjam Korporal-Kuhnke, Simon Faller, Felipe von Glehn, Sven Jarius, Brigitte Wildemann"]},"language":["eng"],"title":[{"title_sort":"Th17 cells","title":"Th17 cells","subtitle":"a prognostic marker for MS rebound after natalizumab cessation?"}],"physDesc":[{"extent":"5 S."}]} | ||
| SRT | |a HAASJUERGETH17CELLS2017 | ||